950210 — Prestige Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Prestige Biopharma, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2019 June 30th	2020 June 30th	2021 June 30th	2022 June 30th	2023 June 30th
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	8.51	38.3	407	235	230
Net Total Accounts Receivable
Net Total Receivables	8.19	2.02	—	—	0.101
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	17.3	41.5	407	241	237
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.905	3.76	5.7	29.7	236
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	89.1	133	535	387	565
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	29.2	7.06	12.4	32.3	103
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	38.7	18.6	25.8	54	222
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	50.4	115	509	333	343
Total Liabilities & Shareholders' Equity	89.1	133	535	387	565
Total Common Shares Outstanding